Funding news
MediLink Therapeutics logo

MediLink Therapeutics Closes $570.0

Recently funded · $570.0M UnknownHospitals and Health CareCNView source

Get the full MediLink Therapeutics company profile

Access contacts, investors, buying signals & more

Open in Dashboard

MediLink Therapeutics, a biotech firm focused on developing next-generation drug conjugates with independent intellectual property, has secured a significant $570.0M in new funding.

This substantial capital injection will accelerate its international efforts to create competitive drug conjugates, which are designed to offer better therapeutic windows for unmet clinical needs. The company aims to continuously upgrade its technologies, establish diverse technology platforms, and expand into new disease areas to serve global patients.

From the source

YongBo · Jan 8, 2026

Article link: https://lnkd.in/dMF62_4d China's healthcare sector saw 16 funding deals May 18–22, 2026. Highlights: Full-Life Tech’s $110M Series D & MediLink Therapeutics’ massive $570M round. #HealthcareVC #MedTech #Biotech

Other China companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
GRAIL logo

GRAIL

United States

$7.1B
4
Illumina logo

Illumina

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Unknown rounds

Companies that recently closed a Unknown round.

#CompanyAmount
1
Maison Sarah Lavoine logo

Maison Sarah Lavoine

France

$15.0K
2
MiRus® logo

MiRus®

United States

$1.5B
3
LemFi logo

LemFi

United Kingdom

$737.0M
4
Scope AI logo

Scope AI

United Kingdom

$14.9M
5
TympaHealth Technologies Ltd logo

TympaHealth Technologies Ltd

United Kingdom

$2.7M